Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 127

Sort by

Sort Order Select

Journal Articles

The Contribution of the Monocyte‐Macrophage Lineage to Immunotherapy Outcomes

Rachael C Adams, Kelli PA MacDonald, Geoffrey R Hill

Blood blood.2024025680.

https://doi.org/10.1182/blood.2024025680

Published: 2024

Journal Articles

Fecal Microbiota Transplantation to Prevent Acute Graft-Versus-Host Disease: First Pre-Planned Interim Analysis of a Randomized Trial

Armin Rashidi, Swetha Reddi, Maryam Ebadi, Liliia Senyshyn, Amanda Kabage, Samuel Minot, Ted Gooley, Stephanie J. Lee, Geoffrey R. Hill, Alexander Khoruts

Blood (2024) 144 (Supplement 1): 2149.

https://doi.org/10.1182/blood-2024-202112

Published: 2024

Journal Articles

Trial in Progress: ST-067 (decoy-resistant IL-18) with Teclistamab in Multiple Myeloma

Rahul Banerjee, Jacquelin Vandermeer, Jeremy Barton, Michael Mangone, Beatrice P. McQueen, Jordan Gauthier, Aaron M Ring, Ajay K. Gopal, Geoffrey R. Hill, Andrew J. Cowan

Blood (2024) 144 (Supplement 1): 7100.

https://doi.org/10.1182/blood-2024-198751

Published: 2024

Journal Articles

Donor XCR1 + and CD11b + Dendritic Cells Determine the Severity of Th1 and Th17-Dependent Acute Gvhd within the Gastrointestinal Tract

Motoko Koyama, Shuichiro Takahashi, Takayuki Inoue, Kathleen S Ensbey, Samuel R. W. Legg, Tomoko Sekiguchi, Ethan Nelson, Nicole S Nemychenkov, Tanvi Joshi, Simone A Minnie, Albert C Yeh, Julie R Boiko, Ping Zhang, Mark B Headley, Jisun Paik, John K Amory, Geoffrey R. Hill

Blood (2024) 144 (Supplement 1): 905.

https://doi.org/10.1182/blood-2024-209473

Published: 2024

Journal Articles

Trials in Progress: Decoy-Resistant Interleukin-18 (DR-18) for Relapse or Pre-Emptive Treatment of Measurable Residual Disease after Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome (DR. DREAM), a Phase I Trial

Elizabeth Krakow, Laura Connelly-Smith, Catherine J. Lee, Dow Dunbar, Jeremy Barton, Beatrice P. McQueen, Geoffrey R. Hill, Jacob S. Appelbaum

Blood (2024) 144 (Supplement 1): 4780.1.

https://doi.org/10.1182/blood-2024-204129

Published: 2024

Journal Articles

Impact of COVID-19 on Multidisciplinary Lymphoma Tumor Boards: An Analysis of Practice and Care Changes

Blood (2024) 144 (Supplement 1): 2283.

https://doi.org/10.1182/blood-2024-210539

Published: 2024

Journal Articles

Cytokines associated with organ manifestations in chronic graft-versus-host disease

Stephanie J. Lee, Ningxin Ma, Timothy Randolph, Carrie L. Kitko, Corey S. Cutler, Najla El Jurdi, George Chen, Betty K. Hamilton, Joseph A. Pidala, Paul A Carpenter, Sally Arai, Lynn Onstad, Sophie Paczesny, Tomoko Sekiguchi, Motoko Koyama, Geoffrey R. Hill

Blood (2024) 144 (Supplement 1): 4902.

https://doi.org/10.1182/blood-2024-203743

Published: 2024

Journal Articles

Single-cell analysis of the multiple myeloma microenvironment after gamma-secretase inhibition and CAR T-cell therapy

David G Coffey, Pinar Ataca Atilla, Erden Atilla, Ola Landgren, Andrew J Cowan, Sylvain Simon, Margot Pont, Melissa L. Comstock, Geoffrey R Hill, Stanley R. Riddell, Damian J Green

Blood blood.2024025231.

https://doi.org/10.1182/blood.2024025231

Published: 2024

Includes: Supplemental data

Journal Articles

Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation

Shuichiro Takahashi, Simone A. Minnie, Kathleen S. Ensbey, Christine R. Schmidt, Tomoko Sekiguchi, Samuel R. W. Legg, Ping Zhang, Motoko Koyama, Stuart D. Olver, Alika D. Collinge, Sara Keshmiri, Melissa L. Comstock, Antiopi Varelias, Damian J. Green, Geoffrey R. Hill

Blood (2024) 143 (16): 1656–1669.

https://doi.org/10.1182/blood.2023022000

Published: 2024

Includes: Supplemental data

Journal Articles

CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice

Rachael C. Adams, Dylan Carter-Cusack, Genesis T. Llanes, Christopher R. Hunter, Janaki Manoja Vinnakota, Marc J. Ruitenberg, Jana Vukovic, Patrick Bertolino, Kirat K. Chand, Julie A. Wixey, Samuel P. Nayler, Geoffrey R. Hill, Scott N. Furlan, Robert Zeiser, Kelli P. A. MacDonald

Blood (2024) 143 (10): 912–929.

https://doi.org/10.1182/blood.2023022040

Published: 2024

Includes: Supplemental data

Journal Articles

Impact of Gamma-Secretase Inhibition on the Multiple Myeloma Immune Microenvironment

David Coffey, Ola Landgren, Andrew J. Cowan, Pinar Ataca Atilla, Sylvain Simon, Margot Pont, Melissa L Comstock, Geoffrey R Hill, Stanley R. Riddell, Damian J Green

Blood (2023) 142 (Supplement 1): 4683.

https://doi.org/10.1182/blood-2023-186980

Published: 2023

Journal Articles

Microbiota-Specific T Cells Contribute to Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 345.

https://doi.org/10.1182/blood-2023-178773

Published: 2023

Journal Articles

CSF1R Inhibition Promotes Neuroinflammation and Behavioural Deficits during Graft-Versus-Host Disease in Mice

Rachael C Adams, Dylan Carter-Cusack, Genesis T Llanes, Christopher R Hunter, Janaki Manoja Vinnakota, Marc Ruitenberg, Jana Vukovic, Patrick Bertolino, Kirat K. Chand, Julie A. Wixey, Samuel P Nayler, Geoffrey R Hill, Scott N Furlan, Robert Zeiser, Kelli PA MacDonald

Blood (2023) 142 (Supplement 1): 2052.

https://doi.org/10.1182/blood-2023-184841

Published: 2023

Journal Articles

MMF Is Associated with Worse OS in CMV Seropositive AML Patients Undergoing MUD HCT with Calcineurin-Inhibitor-Based Gvhd Prophylaxis

Rima M. Saliba, Stephanie J. Lee, Paul A Carpenter, Catherine J. Lee, Geoffrey R Hill, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Rohtesh S. Mehta

Blood (2023) 142 (Supplement 1): 236.

https://doi.org/10.1182/blood-2023-186402

Published: 2023

Journal Articles

BCMA-Directed Low Dose Alpha-Emitter Therapy Eliminates Minimal Residual Disease in a Multiple Myeloma Mouse Xenograft Model

Melissa L Comstock, Shyril O'Steen, Yukang Lin, Donald Hamlin, D Scott Wilbur, Johnnie J. Orozco, Rainer F. Storb, Roland B. Walter, Pinar Ataca Atilla, Brian G Till, Geoffrey R Hill, Brenda M. Sandmaier, Damian J Green

Blood (2023) 142 (Supplement 1): 53.

https://doi.org/10.1182/blood-2023-188055

Published: 2023

Journal Articles

Trogocytosis May Attenuate the Efficacy of Anti-BCMA CAR T Cells Administered in Combination with γ-Secretase Inhibitor

Pinar Ataca Atilla, Sylvain Simon, Erden Atilla, Melissa L Comstock, Andrew J. Cowan, Geoffrey R Hill, Stanley R. Riddell, Damian J Green

Blood (2023) 142 (Supplement 1): 2083.

https://doi.org/10.1182/blood-2023-187132

Published: 2023

Journal Articles

A novel RIPK1 inhibitor attenuates GVHD

Geoffrey R. Hill, Motoko Koyama

Blood (2023) 141 (9): 969–970.

https://doi.org/10.1182/blood.2022019019

Published: 2023

Journal Articles

Lithium attenuates graft-versus-host disease via effects on the intestinal stem cell niche

Motoko Koyama, Luke Samson, Kathleen S. Ensbey, Shuichiro Takahashi, Andrew D. Clouston, Paul J. Martin, Geoffrey R. Hill

Blood (2023) 141 (3): 315–319.

https://doi.org/10.1182/blood.2022015808

Published: 2023

Includes: Supplemental data

Journal Articles

Regulatory T Cell Depletion during Stem Cell Mobilization Enhances Anti-Myeloma Immunity after Experimental Autologous Stem Cell Transplantation

Shuichiro Takahashi, Simone A Minnie, Samuel RW Legg, Christine R Schmidt, Kathleen S Ensbey, Damian J. Green, Geoffrey R Hill

Blood (2022) 140 (Supplement 1): 2086–2087.

https://doi.org/10.1182/blood-2022-168117

Published: 2022

Journal Articles

Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Sawa Ito, Elizabeth F Krakow, Kedwin Ventura, Amy Rodger, Emily Geramita, Erika Moore, Geoffrey R Hill, Warren D Shlomchik

Blood (2022) 140 (Supplement 1): 7678–7679.

https://doi.org/10.1182/blood-2022-157054

Published: 2022

NARROW

The Contribution of the Monocyte‐Macrophage Lineage to Immunotherapy Outcomes

Fecal Microbiota Transplantation to Prevent Acute Graft-Versus-Host Disease: First Pre-Planned Interim Analysis of a Randomized Trial

Trial in Progress: ST-067 (decoy-resistant IL-18) with Teclistamab in Multiple Myeloma

Donor XCR1 + and CD11b + Dendritic Cells Determine the Severity of Th1 and Th17-Dependent Acute Gvhd within the Gastrointestinal Tract

Trials in Progress: Decoy-Resistant Interleukin-18 (DR-18) for Relapse or Pre-Emptive Treatment of Measurable Residual Disease after Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome (DR. DREAM), a Phase I Trial

Impact of COVID-19 on Multidisciplinary Lymphoma Tumor Boards: An Analysis of Practice and Care Changes

Cytokines associated with organ manifestations in chronic graft-versus-host disease

Single-cell analysis of the multiple myeloma microenvironment after gamma-secretase inhibition and CAR T-cell therapy

Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation

CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice

Impact of Gamma-Secretase Inhibition on the Multiple Myeloma Immune Microenvironment

Microbiota-Specific T Cells Contribute to Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation

CSF1R Inhibition Promotes Neuroinflammation and Behavioural Deficits during Graft-Versus-Host Disease in Mice

MMF Is Associated with Worse OS in CMV Seropositive AML Patients Undergoing MUD HCT with Calcineurin-Inhibitor-Based Gvhd Prophylaxis

BCMA-Directed Low Dose Alpha-Emitter Therapy Eliminates Minimal Residual Disease in a Multiple Myeloma Mouse Xenograft Model

Trogocytosis May Attenuate the Efficacy of Anti-BCMA CAR T Cells Administered in Combination with γ-Secretase Inhibitor

A novel RIPK1 inhibitor attenuates GVHD

Lithium attenuates graft-versus-host disease via effects on the intestinal stem cell niche

Regulatory T Cell Depletion during Stem Cell Mobilization Enhances Anti-Myeloma Immunity after Experimental Autologous Stem Cell Transplantation

Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only